Where a generic CV loses pharma and biotech meaning
A milestone in discovery, clinical development, quality, manufacturing, regulatory affairs, or market access carries a different burden of evidence. A generic CV can remove the development phase, therapeutic area, regulated process, decision authority, or cross-functional dependency that makes the contribution credible.
What the dedicated schema must capture
The schema is being designed to separate research, clinical, regulatory, quality, operations, medical, and commercial role families. It must preserve development stage, evidence standard, patient or product consequence, and the boundaries between individual contribution and governed approval.
What it must never infer
The schema must not invent study outcomes, approvals, authorship, validation, compliance, patient impact, or commercial results. Sensitive and unsupported claims remain visible for candidate confirmation.